![Heather Turner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heather Turner
Algemeen Directeur bij Carmot Therapeutics, Inc.
Actieve functies van Heather Turner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The State Bar of California
![]() The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - | - |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Directeur/Bestuurslid | 21-09-2022 | - |
Algemeen Directeur | 01-01-2023 | - | |
President | 01-01-2023 | - | |
Operationeel Directeur | 21-09-2022 | - |
Loopbaan van Heather Turner
Eerdere bekende functies van Heather Turner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LYELL IMMUNOPHARMA, INC. | Algemeen Adviseur | 01-04-2019 | 05-07-2023 |
Bedrijfssecretaris | 01-12-2019 | 05-07-2023 | |
SANGAMO THERAPEUTICS, INC. | Algemeen Adviseur | 12-02-2018 | 15-03-2019 |
Bedrijfssecretaris | - | 15-03-2019 | |
ATARA BIOTHERAPEUTICS, INC. | Algemeen Adviseur | 01-07-2015 | 01-02-2018 |
Bedrijfssecretaris | 01-07-2015 | 01-02-2018 | |
OREXIGEN THERAPEUTICS, INC. | Algemeen Adviseur | 01-06-2007 | 25-06-2015 |
Bedrijfssecretaris | 01-06-2007 | 25-06-2015 | |
Conor Medsystems LLC
![]() Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01-07-2005 | 01-06-2007 |
Cooley LLP
![]() Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-1999 | 01-01-2005 |
Opleiding van Heather Turner
University of California, Santa Barbara | Undergraduate Degree |
UCLA School of Law | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
General Counsel | 4 |
Corporate Secretary | 4 |
Corporate Officer/Principal | 3 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
LYELL IMMUNOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Orexigen Therapeutics, Inc.
![]() Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Conor Medsystems LLC
![]() Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Cooley LLP
![]() Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
The State Bar of California
![]() The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Health Technology |
- Beurs
- Insiders
- Heather Turner
- Ervaring